All data are based on the daily closing price as of September 20, 2024
e

Eiken Chemical

4549.TSE
16.48 USD
-0.20
-1.20%

Overview

Last close
16.48 usd
Market cap
570.33M usd
52 week high
16.84 usd
52 week low
8.87 usd
Target price
17.05 usd

Valuation

P/E
36.2946
Forward P/E
N/A
Price/Sales
2.0441
Price/Book Value
1.7912
Enterprise Value
487.32M usd
EV/Revenue
1.7637
EV/EBITDA
22.3963

Key financials

Revenue TTM
276.30M usd
Gross Profit TTM
142.69M usd
EBITDA TTM
36.78M usd
Earnings per Share
0.45 usd
Dividend
0.35 usd
Total assets
380.55M usd
Net debt
-67.14M usd

About

Eiken Chemical Co., Ltd. engages in the manufacturing and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.
  • Symbol
    4549.TSE
  • Exchange
    TSE
  • Isin
    JP3160700005
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Mr. Tsugunori Notomi
  • Headquarter
    Tokyo
  • Web site
    https://www.eiken.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top